POROS CaptureSelect FibXL Affinity Matrix has specifically been designed for the purification of human fibrinogen from recombinant or plasma source.
Features of this affinity matrix include:
• Fibrinogen purification from human plasma and recombinant sources
• Efficient purification of fibrinogen with high yields and retained activity
• Excellent scalability
• Non-animal derived
• High flow rates
POROS CaptureSelect FibXL Affinity Matrix is an affinity matrix that binds to fibrinogen with high selectivity and yield, enabling a robust, fast, and efficient purification process with excellent purity obtained in one step.
Free of animal components
CaptureSelect products contain affinity ligands based on recombinant single-domain antibody fragments (VHH) created by a proprietary technology. The VHH affinity ligand is a 12 to 15 kDa fragment comprising the three complementarity-determining regions (CDRs) that form the antigen-binding domain, efficiently produced in the yeast Saccharomyces cerevisiae by a production process free of any animal components (Animal Origin-Free).
Main characteristics
Matrix:cross-linked poly(styrene-divinylbenzene)
Average particle size: 50 μm
Ligand:CaptureSelect FibXL affinity ligand
Ligand coupling method:epoxide
Binding capacity:approximately 15 g/L resin (determined with plasma derived fibrinogen)
Elution conditions:acidic elution with 0.1 M glycine pH 3.0; neutral pH elution with 20 mM Tris, 1.0 M MgCl2 and 40%(v/v) propyleneglycol
Mechanical resistance:100 bar (1,450 psi, 10 MPa)
Formulation buffer:20 %(v/v) ethanol
Code | Description |
---|---|
2802912005 | Catalog Number: 2802912005 |
2802912010 | Catalog Number: 2802912010 |
2802912050 | Catalog Number: 2802912050 |